Navigation Links
The CNIO welcomes the new academic year with a spotlight on cancer genetics
Date:9/5/2012

The Distinguished Seminars series, the most prestigious scientific conferences at the Spanish National Cancer Research Centre (CNIO), welcome the new academic year with a double bill focusing on cancer genetics next Thursday and Friday. The conference schedule will last until next June, with over 30 scientific talks of international excellence.

The Nobel laureate Robert Huber, from the Max Planck Institute of Biochemistry (Germany), will give a talk next Thursday, September 6th, on cellular mechanisms used to degrade faulty or unnecessary proteins, processes whose failure can lead to serious diseases. The lecture, titled Intracellular proteolysis, structures, mechanisms and drug design, will be held at the CNIO Auditorium at 12:00.

On Friday 7th, Peter Campbell, researcher at The Wellcome Trust Sanger Institute (UK) and co-director of the Cancer Genome Project in the UK, will explain what scientists hope to learn from the genomic analysis of 50 different tumour types, and its role in future cancer treatments. The talk is titled Interrogating the architecture of cancer genomes and will also be held at the CNIO Auditorium at 12:00 noon.

A talk by Kári Stefánsson is also scheduled for the first half of September. Stefánsson, a neurologist who will give a lecture on Friday 14th titled The genetics of common traits, works for Decode Genetics (Iceland). A company which thanks to an especial agreement has spent the last years studying the medical and genetic data of Icelanders.

Their latest research, published last month, describes the relationship between paternal age and children's susceptibility to some genetic diseases. On its website, Decode Genetics boasts to have discovered "key genetic risk factors for dozens of common diseases, from cardiovascular diseases to cancer."

This ambitious programme brings world leaders in scientific research to Spain every year. The full programme of the Distinguished Seminars series and other conferences organized by the CNIO is available at www.cnio.es, Scientific Events section.
'/>"/>

Contact: Nuria Noriega
nnoriega@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Related biology news :

1. EMBO welcomes 55 leading life scientists as members
2. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
3. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
4. 7 pharmaceutical companies join academic researchers to speed TB drug discovery
5. The academic jungle: Ecosystem model reveals why women are driven out of science
6. Athletic field paint steals spotlight from the grass it covers
7. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
8. Embryonic development protein active in cancer growth
9. BRG1 mutations confer resistance to hormones in lung cancer
10. Genetic variation in East Asians found to explain resistance to cancer drugs
11. Beyond the microscope: Identifying specific cancers using molecular analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
Breaking Biology Technology: